Microbiome and Enteric Signatures in Sepsis-associated Hepatorenal Injury | MicrobiomeTrials← Back to trialsNCT07735182
Microbiome and Enteric Signatures in Sepsis-associated Hepatorenal Injury
RecruitingOBSERVATIONAL
Trial Details
Start: 2026-02-15Est. Completion: 2028-02-14
Enrollment target: 200 participants Locations- First Affiliated hospital of zhejiang university school of medicine, Hangzhou, Zhejiang, China
Other microbiome trials you might be interested in
Autoimmune Diseases of the Nervous SystemNeuromyelitis Optica Spectrum DisorderMultiple SclerosisGuillain-Barre SyndromeAcute Disseminated EncephalomyelitisAutoimmune EncephalitisStiff-Person SyndromeMyasthenia GravisChronic Inflammatory Demyelinating PolyradiculoneuropathyIdiopathic Inflammatory MyopathiesAutoimmune Diseases
Neurological autoimmune diseases are a group of disorders characterized by the abnormal immune response attacking the ne…
Wuhan, ChinaEst. completion Jul 2027
Completed
To evaluate the safety and effectiveness of MynxGrip, in hemostasis of common femoral artery puncture site, compared wit…
Beijing, ChinaCompleted Oct 22, 2020
Acute Kidney Injury Due to Sepsis
The purpose of this Ph2b study is to characterize the dose-response relationship and to evaluate the safety and efficacy…
Birmingham, United StatesCompleted Feb 25, 2026